FilingSEC EDGAR8-K
Estrella Immunopharma Appoints New CEO
· SEC accepted
StageManagement Change
Filing content
Estrella Immunopharma announced the appointment of Cynthia Pussinen as the new CEO and Chairperson, while former CEO Cheng Liu was appointed as Chief Scientific Officer.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…